New Frontiers in Cancer Research: How Chemicals Can Interfere with Cancer Therapies and Implications for Health Policy
http://www.healthandenvironment.org/partnership_calls/9916
http://www.healthandenvironment.org/partnership_calls/9916
Oct 27, 2011
Background Information/Resources
Background Information/Resources
Widely-noted research published recently indicated that the presence of chemicals like BPA and methylparaben can interfere with commonly-used breast cancer therapies. Join CHE on October 27, 2011 at 10:00 a.m. Pacific / 1:00 p.m. Eastern for this call, which will feature the lead author of that study, William Goodson, MD as well as Mhel Kavanaugh-Lynch, MD, MPH, who will discuss health policy opportunities based on this research and other studies associating chemical exposures with breast cancer.
Ted Schettler, MD, MPH will also provide a brief update on new science relevant to this topic, and Steve Heilig, MPH, will facilitate the call.
This call is co-sponsored by CHE's Breast Cancer Working Group.
The call will be facilitated by Elise Miller, MEd, CHE Director. It will last one hour and will be recorded for archival purposes.
Ted Schettler, MD, MPH will also provide a brief update on new science relevant to this topic, and Steve Heilig, MPH, will facilitate the call.
This call is co-sponsored by CHE's Breast Cancer Working Group.
The call will be facilitated by Elise Miller, MEd, CHE Director. It will last one hour and will be recorded for archival purposes.
